KIRSKE DAVID — SEC insider filings

SEC reporting owner CIK 1276750. 15 insider filings on record with FilingPulse; latest filed 2026-10-05.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2021-03-12 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CTI BIOPHARMA CORP (CTIC)EVP, Chief Financial Officer10—16 legs · 289,784 sh · $1,754,09249
X4 Pharmaceuticals, Inc (XFOR)Chief Financial Officer5—3 legs · 37,271 sh · $142,9074

Insider filings — KIRSKE DAVID

FiledFormIssuerReported transactionsSource
2026-10-054X4 Pharmaceuticals, Inc (XFOR)Sale (S): 11,767 @ $2.86EDGAR
2026-07-014X4 Pharmaceuticals, Inc (XFOR)Sale (S): 8,543 @ $4.26EDGAR
2026-05-134X4 Pharmaceuticals, Inc (XFOR)Sale (S): 16,961 @ $4.29EDGAR
2025-10-314X4 Pharmaceuticals, Inc (XFOR)Grant/award (A): 1,552,769 (derivative) @ $0EDGAR
2025-08-144X4 Pharmaceuticals, Inc (XFOR)Grant/award (A): 193,254 @ $0 · Grant/award (A): 1,073,249 (derivative) @ $0 · Grant/award (A): 352,800 (derivative) @ $0EDGAR
2023-06-264CTI BIOPHARMA CORP (CTIC)Code (U): 17,547 @ $9.10 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 315,000 (derivative) · Disposition to issuer (D): 83,396 (derivative) · Disposition to issuer (D): 270,216 (derivative) · Disposition to issuer (D): 340,000 (derivative) · +3 moreEDGAR
2023-03-164CTI BIOPHARMA CORP (CTIC)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2023-01-034CTI BIOPHARMA CORP (CTIC)Option exercise (M): 13,174 @ $0.95 · Sale (S): 13,174 @ $6 · Grant/award (A): 214 @ $5.11 · Option exercise (M): 12,000 @ $0.95 · Sale (S): 12,000 @ $6 · Option exercise (M): 800 @ $0.95 · +10 moreEDGAR
2022-10-064CTI BIOPHARMA CORP (CTIC)Option exercise (M): 1,400 @ $0.95 · Sale (S): 1,400 @ $6.25 · Option exercise (M): 100 @ $0.95 · Sale (S): 100 @ $6.26 · Option exercise (M): 609 @ $0.95 · Sale (S): 609 @ $6.27 · +3 moreEDGAR
2022-10-034CTI BIOPHARMA CORP (CTIC)Option exercise (M): 800 @ $0.95 · Sale (S): 800 @ $6 · Option exercise (M): 100 @ $0.95 · Sale (S): 100 @ $6.01 · Option exercise (M): 139,841 @ $0.95 · Sale (S): 139,841 @ $6.05 · +6 moreEDGAR
2022-09-204CTI BIOPHARMA CORP (CTIC)Grant/award (A): 9,516 @ $2.12 · Option exercise (M): 22,592 @ $0.95 · Sale (S): 22,592 @ $6.02 · Option exercise (M): 22,592 (derivative) @ $0EDGAR
2022-06-174CTI BIOPHARMA CORP (CTIC)Option exercise (M): 10,000 @ $1 · Sale (S): 10,000 @ $6 · Option exercise (M): 50,000 @ $3.30 · Sale (S): 50,000 @ $6.25 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2022-06-164CTI BIOPHARMA CORP (CTIC)Option exercise (M): 10,000 @ $0.95 · Sale (S): 10,000 @ $5.50 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2022-03-114CTI BIOPHARMA CORP (CTIC)Grant/award (A): 1,782 @ $2.12 · Grant/award (A): 1,817 @ $2.11 · Grant/award (A): 280,000 (derivative) @ $0EDGAR
2021-03-124CTI BIOPHARMA CORP (CTIC)Grant/award (A): 3,798 @ $0.98 · Sale (S): 200,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1276750 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs